ICU Medical
(NASDAQ) ICUI
ICU Medical Financials at a Glance
Market Cap
$3.04B
Revenue (TTM)
$2.23B
Net Income (TTM)
$732.00K
EPS (TTM)
$0.02
P/E Ratio
5012.60
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$123.31
Volume
308,662.172
Open
$122.41
Price
$123.31
Volume
308,662.172
Open
$122.41
Previous Close
$123.31
Daily Range
$121.69 - $126.94
52-Week Range
$107.00 - $160.29
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$123.31
Volume
308,662.172
Open
$122.41
Previous Close
$123.31
Daily Range
$121.69 - $126.94
52-Week Range
$107.00 - $160.29
ICUI News
ICU Medical Earnings Are on Deck
ICUI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ICU Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
13,000
CEO
Vivek Jain
Website
www.icumed.comHeadquarters
San Clemente, CA 92673, US
ICUI Financials
Key Financial Metrics (TTM)
Gross Margin
37%
Operating Margin
3%
Net Income Margin
0%
Return on Equity
4%
Return on Capital
2%
Return on Assets
0%
Earnings Yield
0.02%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.04B
Shares Outstanding
24.69M
Volume
308.66K
Short Interest
0.00%
Avg. Volume
284.50K
Financials (TTM)
Gross Profit
$819.65M
Operating Income
$106.95M
EBITDA
$326.54M
Operating Cash Flow
$179.85M
Capital Expenditure
$88.04M
Free Cash Flow
$91.80M
Cash & ST Invst.
$307.96M
Total Debt
$1.39B
ICU Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$540.31M
-14.2%
Gross Profit
$202.13M
-11.1%
Gross Margin
37.41%
N/A
Market Cap
$3.04B
N/A
Market Cap/Employee
$202.97K
N/A
Employees
15,000
N/A
Net Income
$15.73M
+34.0%
EBITDA
$60.79M
-30.5%
Quarterly Fundamentals
Net Cash
$1.08B
+18.7%
Accounts Receivable
$180.51M
-10.9%
Inventory
$615.86M
+5.3%
Long Term Debt
$1.36B
-13.8%
Short Term Debt
$34.67M
-48.0%
Return on Assets
0.02%
N/A
Return on Invested Capital
1.76%
N/A
Free Cash Flow
$35.95M
+164.5%
Operating Cash Flow
$60.60M
+50.8%